Table 3. Comparison of baseline demographics in HCC patients stratified by 4 α-fetoprotein cutoff values in the propensity model.
| Variables | N = 777 in each group | N = 508 in each group | N = 396 in each group | N = 377 in each group | ||||
|---|---|---|---|---|---|---|---|---|
| <20/≧20 ng/mL | p | <200/≧200 ng/mL | p | <400/≧400 ng/mL | p | <1000/≧1000 ng/mL | p | |
| Age ≧65 year (%) | 53/52 | 0.6844 | 51/50 | 0.7065 | 50/49 | 0.6698 | 53/49 | 0.2745 |
| Male (%) | 79/80 | 0.6174 | 75/76 | 0.8273 | 78/76 | 0.6734 | 78/75 | 0.2299 |
| HBV (%) | 52/54 | 0.3341 | 55/57 | 0.3431 | 56/57 | 0.6673 | 57/57 | 1 |
| HCV (%) | 32/32 | 0.9132 | 28/31 | 0.2419 | 28/31 | 0.391 | 29/27 | 0.4166 |
| Alcoholism (%) | 16/18 | 0.1767 | 20/19 | 0.6346 | 21/17 | 0.1509 | 18/21 | 0.1679 |
| CTP class A (%) | 77/78 | 0.7616 | 68/71 | 0.3055 | 67/69 | 0.5417 | 66/67 | 0.7584 |
| Ascites (%) | 21/19 | 0.3392 | 28/25 | 0.2535 | 32/27 | 0.1375 | 34/30 | 0.31 |
| eGFR ≧60 mL/min/1.73m2 | 71/75 | 0.1704 | 73/75 | 0.4755 | 75/74 | 0.9349 | 73/72 | 0.8705 |
| Tumor volume ≧51cm3 | 39/43 | 0.1486 | 58/55 | 0.2821 | 63/63 | 0.9419 | 70/74 | 0.2916 |
| Performance status 0 (%) | 64/62 | 0.2695 | 56/56 | 1 | 48/47 | 0.7759 | 50/49 | 0.6621 |
| Vascular invasion (%) | 17/19 | 0.1651 | 34/29 | 0.0801 | 39/37 | 0.6083 | 44/44 | 0.9415 |
| Diabetes mellitus (%) | 26/23 | 0.1411 | 23/23 | 0.8229 | 23/23 | 1 | 24/24 | 0.8643 |
| BCLC 0/A/B/C/D (%) | (8/26/15/39/12)/(8/25/12/44/10) | 0.1408 | (5/16/14/47/18)/(5/20/15/47/14) | 0.2003 | (4/14/10/51/21)/(2/17/14/52/15) | 0.0594 | (1/10/10/58/21)/(1/11/16/52/20) | 0.1602 |
| Curative treatments (%) | 54/51 | 0.1701 | 41/40 | 0.8985 | 36/37 | 0.8248 | 35/31 | 0.2788 |